# Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

> **NCT05703295** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 40 (estimated)

## Conditions studied

- Sentinel Lymph Node Biopsy

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT05703295
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05703295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05703295, "Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05703295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*